Investigating the human leukocyte antigen (HLA) system in diffuse toxic goiter (DTG) can predict disease severity, treatment choices, and patient outcomes. HLA markers offer valuable insights for managing DTG effectively.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: